首页 > 最新文献

中华内科杂志最新文献

英文 中文
[Progress in research of autoimmune hepatitis]. [自身免疫性肝炎研究进展]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240402-00213
Y Wei, L Wang, F C Zhang
{"title":"[Progress in research of autoimmune hepatitis].","authors":"Y Wei, L Wang, F C Zhang","doi":"10.3760/cma.j.cn112138-20240402-00213","DOIUrl":"10.3760/cma.j.cn112138-20240402-00213","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological investigation and risk factors of diabetic retinopathy in Yunnan Province]. [云南省糖尿病视网膜病变的流行病学调查及风险因素]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20230928-00168
L Shi, X M Xia, X H Hou, J F Liu, X Nian, Y Jiang, Y X Song, Y S Xu

To investigate the prevalence and epidemiological characteristics of diabetic retinopathy (DR) in Yunnan Province, explore its risk factors, and provide a basis for the prevention and treatment of chronic complications of diabetes mellitus (DM). This is a large cross-sectional study, in all, 1 524 DM patients in 16 communities and villages of Yunnan Province who were registered in health service centers were included in this study from August to November 2019. All patients completed a uniform questionnaire, anthropometric measurements, biochemical measurements, and auxiliary examinations. Logistic regression analysis was used to screen the risk factors of DR. The prevalence rates of DR, mild non-proliferative DR (mild-NPDR), and referable DR (RDR) were 16.0% (244/1 524), 4.5% (69/1 524), and 11.5% (175/1 524), respectively. Glycated hemoglobin A1c (HbA1c)≥7.0% was the risk factor of mild-NPDR (OR=1.872, 95%CI 1.055-3.323) and RDR (OR=4.821, 95%CI 2.917-7.969). Blood pressure≥130/80 mmHg (1 mmHg=0.133 kPa) was the risk factor of mild-NPDR (OR=1.933, 95%CI 1.112-3.358) and RDR (OR=1.505, 95%CI 1.063-2.130). In Yunnan Province, 16.0% DM patients had accompanying DR, wherein about 71.7% of them required an ophthalmology referral, and the high incidence of RDR in DM patients was associated with poor control of blood glucose and blood pressure.

为调查云南省糖尿病视网膜病变(DR)的患病率及流行病学特征,探讨其危险因素,为糖尿病(DM)慢性并发症的防治提供依据。本研究是一项大型横断面研究,共纳入2019年8月至11月期间云南省16个社区和村卫生服务中心登记在册的1524名DM患者。所有患者均完成了统一的问卷调查、人体测量、生化测量和辅助检查。采用 Logistic 回归分析筛选 DR 的风险因素。DR、轻度非增生性DR(mild-NPDR)和可转诊DR(RDR)的患病率分别为16.0%(244/1 524)、4.5%(69/1 524)和11.5%(175/1 524)。糖化血红蛋白 A1c(HbA1c)≥7.0% 是轻度-NPDR(OR=1.872,95%CI 1.055-3.323)和 RDR(OR=4.821,95%CI 2.917-7.969)的风险因素。血压≥130/80 mmHg(1 mmHg=0.133 kPa)是轻度 NPDR(OR=1.933,95%CI 1.112-3.358)和 RDR(OR=1.505,95%CI 1.063-2.130)的危险因素。在云南省,16.0%的DM患者伴有DR,其中约71.7%需要眼科转诊,DM患者RDR的高发生率与血糖和血压控制不佳有关。
{"title":"[Epidemiological investigation and risk factors of diabetic retinopathy in Yunnan Province].","authors":"L Shi, X M Xia, X H Hou, J F Liu, X Nian, Y Jiang, Y X Song, Y S Xu","doi":"10.3760/cma.j.cn112138-20230928-00168","DOIUrl":"10.3760/cma.j.cn112138-20230928-00168","url":null,"abstract":"<p><p>To investigate the prevalence and epidemiological characteristics of diabetic retinopathy (DR) in Yunnan Province, explore its risk factors, and provide a basis for the prevention and treatment of chronic complications of diabetes mellitus (DM). This is a large cross-sectional study, in all, 1 524 DM patients in 16 communities and villages of Yunnan Province who were registered in health service centers were included in this study from August to November 2019. All patients completed a uniform questionnaire, anthropometric measurements, biochemical measurements, and auxiliary examinations. Logistic regression analysis was used to screen the risk factors of DR. The prevalence rates of DR, mild non-proliferative DR (mild-NPDR), and referable DR (RDR) were 16.0% (244/1 524), 4.5% (69/1 524), and 11.5% (175/1 524), respectively. Glycated hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>)≥7.0% was the risk factor of mild-NPDR (<i>OR</i>=1.872, 95%<i>CI</i> 1.055-3.323) and RDR (<i>OR</i>=4.821, 95%<i>CI</i> 2.917-7.969). Blood pressure≥130/80 mmHg (1 mmHg=0.133 kPa) was the risk factor of mild-NPDR (<i>OR</i>=1.933, 95%<i>CI</i> 1.112-3.358) and RDR (<i>OR</i>=1.505, 95%<i>CI</i> 1.063-2.130). In Yunnan Province, 16.0% DM patients had accompanying DR, wherein about 71.7% of them required an ophthalmology referral, and the high incidence of RDR in DM patients was associated with poor control of blood glucose and blood pressure.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Thyroid nodules: individualized treatment based on precision diagnosis]. [甲状腺结节:基于精准诊断的个体化治疗]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240409-00223
Y S Li, Z Y Shan
{"title":"[Thyroid nodules: individualized treatment based on precision diagnosis].","authors":"Y S Li, Z Y Shan","doi":"10.3760/cma.j.cn112138-20240409-00223","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240409-00223","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Primary biliary cholangitis and autoimmune hepatitis overlap syndrome complicated with skin and soft tissue infection of lower limb during corticosteroids treatment: a case report]. [原发性胆汁性胆管炎和自身免疫性肝炎重叠综合征并发皮质类固醇治疗期间下肢皮肤和软组织感染:病例报告]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20231030-00263
S Q Li, Y Song, F Zhou, M Y Chen, L G Chen, J P Zhou
{"title":"[Primary biliary cholangitis and autoimmune hepatitis overlap syndrome complicated with skin and soft tissue infection of lower limb during corticosteroids treatment: a case report].","authors":"S Q Li, Y Song, F Zhou, M Y Chen, L G Chen, J P Zhou","doi":"10.3760/cma.j.cn112138-20231030-00263","DOIUrl":"10.3760/cma.j.cn112138-20231030-00263","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Exploratory analysis of gut microbiota differences in patients with bronchial asthma of different inflammatory types]. [不同炎症类型支气管哮喘患者肠道微生物群差异的探索性分析]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240207-00103
W Yan, X Q Li, B B Liu, X Y Sun, W Y Wu, N Shen

Objective: To observe the characteristics and differences of gut microbiota in asthma patients with different inflammatory types through metagenomic analysis. Methods: Adults aged ≥18 years who visited the Respiratory Clinic of Peking University Third Hospital from August 1, 2021 to August 31, 2022 and were primarily diagnosed with asthma were selected as the study subjects. Finally, 29 patients with stable asthma were included. Fresh fecal samples were collected and the fecal DNA was extracted for high-throughput 16sRNA sequencing of gut microbiota. The diversity and community structure of gut microbiota in different groups of asthma patients were compared, and the species differences were analyzed through random forest and LEfSe analysis. Results: There were sex-based differences in asthma patients with different types of inflammation, and the proportion of female patients was higher in neutrophilic asthma patients (χ2=4.14, P=0.042). There was no significant intergroup difference in the alpha diversity of gut microbiota among asthma patients with different inflammatory types, but there were significant differences in the microbiome. Patients with neutrophilic asthma had higher relative abundance of Bacillales (P=0.029) and Oscillospiraceae (P=0.015). In species LEfSe analysis, patients with eosinophilic asthma had a higher relative abundance of fungi. Conclusion: There are intergroup differences in the gut microbiota of asthma patients with different inflammation types, and fungi are biomarkers that distinguish the differences in gut microbiota between patients with eosinophilic asthma and neutrophilic asthma.

目的通过元基因组分析观察不同炎症类型的哮喘患者肠道微生物群的特征和差异。方法选取 2021 年 8 月 1 日至 2022 年 8 月 31 日在北京大学第三医院呼吸科就诊的年龄≥18 岁、主要诊断为哮喘的成人作为研究对象。最后,29 名稳定期哮喘患者被纳入研究。收集新鲜粪便样本并提取粪便DNA,用于肠道微生物群的高通量16sRNA测序。比较了不同组哮喘患者肠道微生物群的多样性和群落结构,并通过随机森林和 LEfSe 分析法分析了物种差异。结果发现不同炎症类型的哮喘患者存在性别差异,嗜中性粒细胞哮喘患者中女性比例更高(χ2=4.14,P=0.042)。不同炎症类型的哮喘患者在肠道微生物群的α多样性方面没有明显的组间差异,但在微生物组方面存在明显差异。嗜中性粒细胞性哮喘患者的芽孢杆菌属(P=0.029)和鞘翅目(Oscillospiraceae)相对丰度较高(P=0.015)。在物种 LEfSe 分析中,嗜酸性粒细胞性哮喘患者的真菌相对丰度较高。结论不同炎症类型的哮喘患者的肠道微生物群存在组间差异,真菌是区分嗜酸性粒细胞性哮喘和嗜中性粒细胞性哮喘患者肠道微生物群差异的生物标志物。
{"title":"[Exploratory analysis of gut microbiota differences in patients with bronchial asthma of different inflammatory types].","authors":"W Yan, X Q Li, B B Liu, X Y Sun, W Y Wu, N Shen","doi":"10.3760/cma.j.cn112138-20240207-00103","DOIUrl":"10.3760/cma.j.cn112138-20240207-00103","url":null,"abstract":"<p><p><b>Objective:</b> To observe the characteristics and differences of gut microbiota in asthma patients with different inflammatory types through metagenomic analysis. <b>Methods:</b> Adults aged ≥18 years who visited the Respiratory Clinic of Peking University Third Hospital from August 1, 2021 to August 31, 2022 and were primarily diagnosed with asthma were selected as the study subjects. Finally, 29 patients with stable asthma were included. Fresh fecal samples were collected and the fecal DNA was extracted for high-throughput 16sRNA sequencing of gut microbiota. The diversity and community structure of gut microbiota in different groups of asthma patients were compared, and the species differences were analyzed through random forest and LEfSe analysis. <b>Results:</b> There were sex-based differences in asthma patients with different types of inflammation, and the proportion of female patients was higher in neutrophilic asthma patients (<i>χ</i><sup>2</sup>=4.14, <i>P</i>=0.042). There was no significant intergroup difference in the alpha diversity of gut microbiota among asthma patients with different inflammatory types, but there were significant differences in the microbiome. Patients with neutrophilic asthma had higher relative abundance of <i>Bacillales</i> (<i>P</i>=0.029) and <i>Oscillospiraceae</i> (<i>P</i>=0.015). In species LEfSe analysis, patients with eosinophilic asthma had a higher relative abundance of fungi. <b>Conclusion:</b> There are intergroup differences in the gut microbiota of asthma patients with different inflammation types, and fungi are biomarkers that distinguish the differences in gut microbiota between patients with eosinophilic asthma and neutrophilic asthma.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on the relationship between hemoglobin glycosylation index and arteriosclerosis- related blood lipids]. [血红蛋白糖基化指数与动脉硬化相关血脂的关系研究]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20231124-00338
C Zhang, L Lin, D Sun, J T Dou, A P Wang, L G Dong, S Y Wang, Z H Lyu, Y M Mu

Objective: To study the relationship between hemoglobin glycation index (HGI) and blood lipid indices such as low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and plasma atherogenic index (AIP). Methods: This cross-sectional study included 16 049 participants from the Beijing Apple Garden community between December 2011 and August 2012. The subjects were divided into three groups based on the HGI quartile: low (n=5 388), medium (n=5 249), and high (n=5 412). The differences in blood lipid indicators between different HGI groups were compared and multivariate logistic regression model was established to analyze the association between HGI and dyslipidemia. And multivariate logistic regression model was established to analyze the relationship between HGI and blood lipid indicators in different glucose metabolism populations. Results: There were 16 049 participants in all (mean age: 56 years), including 10 452 women (65.1%). They were classified into normal glucose tolerance (9 093 cases), prediabetes (4 524 cases), and diabetes (2 432 cases) based on glucose tolerance status. In the general population, with the increase of HGI, LDL-C, non-HDL-C, and AIP gradually increased (all P values for trends were <0.05), and the proportion of abnormalities increased significantly (χ2=101.40, 42.91, 39.80; all P<0.001). A multivariate logistic regression model was established, which suggested a significant correlation between HGI and LDL-C, non-HDL-C, and AIP (all P<0.05), after adjusting for factors such as age, sex, fasting blood glucose, hypertension, body mass index, smoking, and alcohol consumption. In the overall population, normal glucose tolerance group, and diabetes group, HGI had the highest correlation with non-HDL-C (OR values of 1.325, 1.678, and 1.274, respectively); in the prediabetes group, HGI had a higher correlation with LDL-C (OR value: 1.510); and in different glucose metabolism groups, AIP and HGI were both correlated (OR: 1.208-1.250), but not superior to non-HDL-C and LDL-C. Conclusion: HGI was closely related to LDL-C, non HDL-C, and AIP in the entire population and people with different glucose metabolism, suggesting that HGI may be a predictor of atherosclerotic cardiovascular disease.

目的研究血红蛋白糖化指数(HGI)与低密度脂蛋白胆固醇(LDL-C)、非高密度脂蛋白胆固醇(non-HDL-C)和血浆致动脉粥样硬化指数(AIP)等血脂指标之间的关系。研究方法这项横断面研究纳入了 2011 年 12 月至 2012 年 8 月期间北京苹果园社区的 16 049 名参与者。根据 HGI 四分位数将受试者分为三组:低(5 388 人)、中(5 249 人)和高(5 412 人)。比较不同 HGI 组血脂指标的差异,并建立多变量 logistic 回归模型,分析 HGI 与血脂异常的关系。并建立多变量逻辑回归模型,分析不同糖代谢人群中 HGI 与血脂指标的关系。结果共有 16 049 名参与者(平均年龄:56 岁),包括 10 452 名女性(65.1%)。根据糖耐量状况,他们被分为糖耐量正常(9 093 例)、糖尿病前期(4 524 例)和糖尿病(2 432 例)。在普通人群中,随着 HGI 的增加,低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和 AIP 逐渐增加(趋势的 P 值分别为 χ2=101.40、42.91、39.80;PPOR 值分别为 1.325、1.678 和 1.分别为1.325、1.678、1.274);在糖尿病前期组中,HGI与LDL-C的相关性更高(OR值:1.510);在不同糖代谢组中,AIP与HGI均有相关性(OR值:1.208-1.250),但不优于非HDL-C和LDL-C。结论在整个人群和不同糖代谢人群中,HGI与低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和AIP密切相关,这表明HGI可能是动脉粥样硬化性心血管疾病的预测因子。
{"title":"[Study on the relationship between hemoglobin glycosylation index and arteriosclerosis- related blood lipids].","authors":"C Zhang, L Lin, D Sun, J T Dou, A P Wang, L G Dong, S Y Wang, Z H Lyu, Y M Mu","doi":"10.3760/cma.j.cn112138-20231124-00338","DOIUrl":"10.3760/cma.j.cn112138-20231124-00338","url":null,"abstract":"<p><p><b>Objective:</b> To study the relationship between hemoglobin glycation index (HGI) and blood lipid indices such as low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and plasma atherogenic index (AIP). <b>Methods:</b> This cross-sectional study included 16 049 participants from the Beijing Apple Garden community between December 2011 and August 2012. The subjects were divided into three groups based on the HGI quartile: low (<i>n</i>=5 388), medium (<i>n</i>=5 249), and high (<i>n</i>=5 412). The differences in blood lipid indicators between different HGI groups were compared and multivariate logistic regression model was established to analyze the association between HGI and dyslipidemia. And multivariate logistic regression model was established to analyze the relationship between HGI and blood lipid indicators in different glucose metabolism populations. <b>Results:</b> There were 16 049 participants in all (mean age: 56 years), including 10 452 women (65.1%). They were classified into normal glucose tolerance (9 093 cases), prediabetes (4 524 cases), and diabetes (2 432 cases) based on glucose tolerance status. In the general population, with the increase of HGI, LDL-C, non-HDL-C, and AIP gradually increased (all <i>P</i> values for trends were <0.05), and the proportion of abnormalities increased significantly (<i>χ</i><sup>2</sup>=101.40, 42.91, 39.80; all <i>P</i><0.001). A multivariate logistic regression model was established, which suggested a significant correlation between HGI and LDL-C, non-HDL-C, and AIP (all <i>P</i><0.05), after adjusting for factors such as age, sex, fasting blood glucose, hypertension, body mass index, smoking, and alcohol consumption. In the overall population, normal glucose tolerance group, and diabetes group, HGI had the highest correlation with non-HDL-C (<i>OR</i> values of 1.325, 1.678, and 1.274, respectively); in the prediabetes group, HGI had a higher correlation with LDL-C (<i>OR</i> value: 1.510); and in different glucose metabolism groups, AIP and HGI were both correlated (<i>OR:</i> 1.208-1.250), but not superior to non-HDL-C and LDL-C. <b>Conclusion:</b> HGI was closely related to LDL-C, non HDL-C, and AIP in the entire population and people with different glucose metabolism, suggesting that HGI may be a predictor of atherosclerotic cardiovascular disease.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Precision diagnosis of thyroid nodules]. [甲状腺结节的精确诊断]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240311-00155
H R Li, R L Han, L Ye
{"title":"[Precision diagnosis of thyroid nodules].","authors":"H R Li, R L Han, L Ye","doi":"10.3760/cma.j.cn112138-20240311-00155","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240311-00155","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Risk factors of thyroid nodules]. [甲状腺结节的风险因素]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240301-00137
W Zhao, X Y Li, Z N Gao
{"title":"[Risk factors of thyroid nodules].","authors":"W Zhao, X Y Li, Z N Gao","doi":"10.3760/cma.j.cn112138-20240301-00137","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240301-00137","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progresses and hot spots of thyroid diseases in the past decade]. [过去十年甲状腺疾病的进展与热点]。
Pub Date : 2024-06-01 DOI: 10.3760/cma.j.cn112138-20240409-00224
Z Y Shan, W P Teng
{"title":"[Progresses and hot spots of thyroid diseases in the past decade].","authors":"Z Y Shan, W P Teng","doi":"10.3760/cma.j.cn112138-20240409-00224","DOIUrl":"10.3760/cma.j.cn112138-20240409-00224","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research advances on mesenchymal stem cell-mediated mitochondrial transfer for improving lung injury and repair in acute respiratory distress syndrome]. [间充质干细胞介导线粒体转移改善急性呼吸窘迫综合征肺损伤和修复的研究进展]。
Pub Date : 2024-05-01 DOI: 10.3760/cma.j.cn112138-20231024-00242
S S Meng, J L Wang, Y Z Huang
{"title":"[Research advances on mesenchymal stem cell-mediated mitochondrial transfer for improving lung injury and repair in acute respiratory distress syndrome].","authors":"S S Meng, J L Wang, Y Z Huang","doi":"10.3760/cma.j.cn112138-20231024-00242","DOIUrl":"10.3760/cma.j.cn112138-20231024-00242","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华内科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1